Biotech Series A Investors & VC Firms
1596 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Stoic VC
SydneyPre-Seed–Series A$65K – $650K
5 people
Elad Gil
San FranciscoSeed–Growth$100K – $10M
1 person
Amplitude Venture Capital
MontrealSeed–Late Stage
16 people
B-FLEXION
St. HelierSeed–Late Stage$500K
13 people
Biovance Capital Partners SCR
LisbonSeed–Series A
16 people
Bridge Bank
San FranciscoSeed–Late Stage
16 people
Cicada Innovations
SydneySeed–Series A
16 people
Delft Enterprises B.V.
DelftPre-Seed–Series A
16 people
Infinitas Capital
Pre-Seed–Late Stage
16 people
Nimbus Synergies Inc.
VancouverPre-Seed–Series A$250K – $2M
13 people
Parallel 18
San JuanPre-Seed–Growth
16 people
Vertex Venture Management Pte. Ltd.
SingaporePre-Seed–Growth
16 people
Better Bite Ventures
Pre-Seed–Series A
5 people
Detong Capital
ShanghaiSeed–Late Stage$20M
11 people
Suncoast Ventures
Walnut CreekPre-Seed–Series A
14 people
Ev3 Ventures Llc
New YorkPre-Seed–Series A$500K – $3M
2 people
Bison Ventures
SeattleSeed–Series A
7 people
Germin8 Ventures
ChicagoSeed–Series B
10 people
Borealis Ventures
HanoverPre-Seed–Series A$1M – $2.5M
12 people
Business Growth Fund
LondonSeed–Growth$3.8M – $38M
9 people
Decacorn Capital
SingaporeSeed–Series B$300K – $600K
12 people
Impact Ventures
BudapestSeed–Series A$378K – $1.6M
6 people
ORI Capital
Hong KongPre-Seed–Late Stage
15 people
Texas Ventures
HoustonSeed–Late Stage
6 people
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)
Data sourced from public filings and firms' own websites — see our methodology.

































/f/233941/5455x4091/7f3c8a93e9/chua-kee-lock.jpg)
/f/233941/5455x4091/3b9777c68f/chow-shangwei.jpg)
/f/233941/5455x4091/c466077ae2/jeff-chang.jpg)
/f/233941/5455x4091/a7c425fe00/cheah-sui-ling.jpeg)






















.webp&w=3840&q=75)
